hs-10342
Small moleculeexperimental
Clinical trial activity
2 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jun 20, 2019 (NCT04060511)
Timeline
Indications
Mechanism of action
- Cyclin-dependent kinase 6INHIBITOR
CDK6 inhibitor
- Cyclin-dependent kinase 4INHIBITOR
CDK4 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05044988 | Phase 2 | Sep 30, 2021 | Jiangsu Hansoh Pharmaceutical Co., Ltd. |
| NCT04060511 | Phase 1 | Jun 20, 2019 | Chinese Academy of Medical Sciences, Henan Medical University, Jiangsu Hansoh Pharmaceutical Co., Ltd., Nanjing Medical University, Sun Yat-Sen University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Jiangsu Hansoh Pharmaceutical Co., Ltd. | For profit | 2 | 2 | 2 | 2019 |
| Chinese Academy of Medical Sciences | Academic/Hospital | 1 | 0 | 1 | 2019 |
| Henan Medical University | Academic/Hospital | 1 | 0 | 1 | 2019 |
| Nanjing Medical University | Academic/Hospital | 1 | 0 | 1 | 2019 |
| Sun Yat-Sen University | Academic/Hospital | 1 | 0 | 1 | 2019 |
5 organizations
Page 1 / 1